ILLUMINA COVIDSEQ Trademark

Trademark Overview


On Wednesday, April 29, 2020, a trademark application was filed for ILLUMINA COVIDSEQ with the United States Patent and Trademark Office. The USPTO has given the ILLUMINA COVIDSEQ trademark a serial number of 88983897. The federal status of this trademark filing is REGISTERED as of Tuesday, November 29, 2022. This trademark is owned by Illumina, Inc.. The ILLUMINA COVIDSEQ trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use; Diagnostic reagents and preparations, other than for medical or veterinary use; Kits comprised principally of reagents with a protocol for use thereof for non-medical purposes; Agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, genetic testing, and genetics, not for medical or veterinary purposes; Kits comprising nucleotides, reagents, enzymes, agents, assays, buffers, chemical preparations, and biological preparations for scientific and research use including in the fields of nucleic acid seq...

Agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use; Diagnostic reagents and preparations, other than for medical or veterinary use; Kits comprised principally of reagents with a protocol for use thereof for non-medical purposes; Agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, agriculture, forensics, food safety, genetic testing, and genetics, not for medical or veterinary purposes; Kits comprising nucleotides, reagents, enzymes, agents, assays, buffers, chemical preparations, and biological preparations for scientific and research use includ...
illumina covidseq

General Information


Serial Number88983897
Word MarkILLUMINA COVIDSEQ
Filing DateWednesday, April 29, 2020
Status700 - REGISTERED
Status DateTuesday, November 29, 2022
Registration Number6913584
Registration DateTuesday, November 29, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 8, 2021

Trademark Statements


Goods and ServicesAgents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use; Diagnostic reagents and preparations, other than for medical or veterinary use; Kits comprised principally of reagents with a protocol for use thereof for non-medical purposes; Agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, genetic testing, and genetics, not for medical or veterinary purposes; Kits comprising nucleotides, reagents, enzymes, agents, assays, buffers, chemical preparations, and biological preparations for scientific and research use including in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, genetic testing, and genetics, not for medical or veterinary purposes; all of the foregoing for the detection of or in the field of COVID-19
Goods and ServicesAgents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use; Diagnostic reagents and preparations, other than for medical or veterinary use; Kits comprised principally of reagents with a protocol for use thereof for non-medical purposes; Agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, agriculture, forensics, food safety, genetic testing, and genetics, not for medical or veterinary purposes; Kits comprising nucleotides, reagents, enzymes, agents, assays, buffers, chemical preparations, and biological preparations for scientific and research use including in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, agriculture, forensics, food safety, genetic testing, and genetics, not for medical or veterinary purposes; all of the foregoing for the detection of or in the field of COVID-19

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, May 12, 2020
Primary Code001
First Use Anywhere DateThursday, May 14, 2020
First Use In Commerce DateTuesday, June 9, 2020

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 12, 2020
Primary Code005
First Use Anywhere DateThursday, May 14, 2020
First Use In Commerce DateTuesday, June 9, 2020

Trademark Owner History


Party NameIllumina, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92122

Party NameIllumina, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92122

Party NameIllumina, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92122

Trademark Events


Event DateEvent Description
Tuesday, November 29, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 29, 2022REGISTERED-PRINCIPAL REGISTER
Friday, October 28, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, October 27, 2022ELECTRONIC RECORD REVIEW COMPLETE
Friday, October 21, 2022ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, October 20, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, October 19, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, October 17, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 17, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 17, 2022ASSIGNED TO LIE
Wednesday, September 7, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 20, 2022TEAS EXTENSION RECEIVED
Tuesday, March 8, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 8, 2022NON-FINAL ACTION E-MAILED
Tuesday, March 8, 2022SU - NON-FINAL ACTION - WRITTEN
Thursday, March 3, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, February 16, 2022USE AMENDMENT FILED
Thursday, March 3, 2022DIVISIONAL PROCESSING COMPLETE
Wednesday, February 16, 2022DIVISIONAL REQUEST RECEIVED
Thursday, March 3, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 16, 2022TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, February 16, 2022TEAS STATEMENT OF USE RECEIVED
Thursday, February 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 1, 2022SOU EXTENSION 1 GRANTED
Tuesday, February 1, 2022SOU EXTENSION 1 FILED
Tuesday, February 1, 2022TEAS EXTENSION RECEIVED
Tuesday, August 3, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 8, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 8, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 19, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 3, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 30, 2021EXAMINER'S AMENDMENT ENTERED
Friday, April 30, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, April 30, 2021EXAMINERS AMENDMENT E-MAILED
Friday, April 30, 2021EXAMINERS AMENDMENT -WRITTEN
Thursday, April 22, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 21, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 21, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 21, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 21, 2020NON-FINAL ACTION E-MAILED
Wednesday, October 21, 2020NON-FINAL ACTION WRITTEN
Monday, October 19, 2020ASSIGNED TO EXAMINER
Monday, October 19, 2020ASSIGNED TO EXAMINER
Tuesday, May 12, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, May 2, 2020NEW APPLICATION ENTERED IN TRAM